Search by Drug Name or NDC

    NDC 00641-6002-10 Ativan 4 mg/mL Details

    Ativan 4 mg/mL

    Ativan is a INTRAMUSCULAR; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is LORAZEPAM.

    Product Information

    NDC 00641-6002
    Product ID 0641-6002_209b0091-c890-4f69-a693-d0594c2606fe
    Associated GPIs 57100060002010
    GCN Sequence Number 003756
    GCN Sequence Number Description lorazepam VIAL 4 MG/ML INJECTION
    HIC3 H21
    HIC3 Description SEDATIVE-HYPNOTICS - BENZODIAZEPINES
    GCN 14141
    HICL Sequence Number 004846
    HICL Sequence Number Description LORAZEPAM
    Brand/Generic Brand
    Proprietary Name Ativan
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lorazepam
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAMUSCULAR; INTRAVENOUS
    Active Ingredient Strength 4
    Active Ingredient Units mg/mL
    Substance Name LORAZEPAM
    Labeler Name Hikma Pharmaceuticals USA Inc.
    Pharmaceutical Class Benzodiazepine [EPC], Benzodiazepines [CS]
    DEA Schedule CIV
    Marketing Category NDA
    Application Number NDA018140
    Listing Certified Through 2024-12-31

    Package

    NDC 00641-6002-10 (00641600210)

    NDC Package Code 0641-6002-10
    Billing NDC 00641600210
    Package 10 VIAL in 1 CARTON (0641-6002-10) / 10 mL in 1 VIAL (0641-6002-01)
    Marketing Start Date 1980-07-25
    NDC Exclude Flag N
    Pricing Information N/A